Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Venice Servellita, Abdullah M. Syed, Mary Kate Morris, Noah Brazer, Prachi Saldhi, Miguel Garcia-Knight, Bharath Sreekumar, Mir M. Khalid, Alison Ciling, Peiyi Chen, G. Renuka Kumar, Amelia S. Gliwa, Jenny Nguyen, Alicia Sotomayor-González, Yueyuan Zhang, Edwin C. Frias, John C. Prostko, John Hackett, Raul Andino, Debra A. Wadford, Carl V. Hanson, Jennifer A. Doudna, Mélanie Ott, Charles Y. Chiu
Topics & Concepts
TiterVirologyBiologyImmunityNeutralizing antibodyDeltaAsymptomaticVirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AntibodyAntibody titerImmunologyMicrobiologyImmune systemMedicineInfectious disease (medical specialty)DiseaseInternal medicineAerospace engineeringEngineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing